← Back to Patent Explorer
US4223020A Expired / Lapsed US ⏱️ 0.0 years remaining

Synthetic peptides having pituitary growth hormone releasing activity

Assignee: SmithKline Beecham Corp
•
Filing: 1979-03-30
•
Granted: 1980-09-16
•
Expires: 1999-03-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel tetrapeptides having the following amino acid sequence X--Y--Z--E--G--J wherein X is selected from a group consisting of --NH 2 , --NHCH 3 , and --N(CH 3 ) 2 ; Y and G are independently selected from a group consisting of tyrosine, tryptophan, and phenylalanine; Z and E are independently selected from a group consisting of D-tyrosine, D-tryptophan, and D-phenylalanine; and J is a C-terminal functional group selected from a group consisting of amide, amide lower alkyl, amide di(lower alkyl), lower alkoxy, hydroxy, and carboxy and the lower ester derivatives thereof; and the pharmaceutically acceptable salts thereof. These peptides act directly on the pituitary to release growth hormone therefrom.

Inventors

  • 👤 Frank A. Momany

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 18:04
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/10; C07K5/1024; C07K14/00; C07K14/435; C07K14/575; C07K14/60; C07K5/08; C07K5/0802; C07K5/0812; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/12

Claims Analysis

Total Claims: 37
Claim 1
Independent Claim 120 words
A peptide having the formula X-Y-Z-E-G-J and the pharmaceutically acceptable non-toxic acid addition salts thereof, wherein X is selected from a group consisting of --NH 2 , --NHCH 3 , and --N(CH 3 ) 2 ; Y and G are independently selected from a group consisting of Tyr, Trp, and Phe; Z and E are independently selected from a group consisting of D-Tyr, D-Trp, and D-Phe; and J is selected from a group consisting of --CONH 2 , --CONHR, --CONR 1 R 2 , --CH 2 OR, --CH 2 OH, --COOH, and --COOR, wherein each R, R 1 , and R 2 is independently selected from a group consisting of straight and branched chain alkyl groups containing 1-6 carbon atoms.
Claim 2
Dependent Claim 120 words
A peptide having the formula X-Y-Z-E-G-J and the pharmaceutically acceptable non-toxic acid addition salts thereof, wherein X is selected from a group consisting of --NH 2 , --NHCH 3 , and --N(CH 3 ) 2 ; Y and G are independently selected from a group consisting of Tyr, Trp, and Phe; Z and E are independently selected from a group consisting of D-Tyr, D-Trp, and D-Phe; and J is selected from a group consisting of --CONH 2 , --CONHR, --CONR 1 R 2 , --CH 2 OR, --CH 2 OH, --COOH, and --COOR, wherein each R, R 1 , and R 2 is independently selected from a group consisting of straight and branched chain alkyl groups containing 1-6 carbon atoms.
Claim 3
Dependent Claim 28 words
The peptide of claim 1 wherein each R, R 1 , and R 2 is independently selected from the group consisting of alkyl groups containing 1-2 carbon atoms.
Claim 4
Dependent Claim 11 words
The peptide of claim 1 wherein J is --CONH 2 .
Claim 5
Dependent Claim 33 words
The peptide of claim 1 having the formula X-Y-D-Trp-E-G-J wherein E is selected from a group consisting of D-Trp and D-Phe; and G is selected from a group consisting of Trp and Phe.
Claim 6
Dependent Claim 9 words
The peptide of claim 4 having the formula X-Tyr-D-Trp-D-Trp-Trp-J.
Claim 7
Dependent Claim 9 words
The peptide of claim 4 having the formula X-Tyr-D-Trp-D-Trp-Phe-J.
Claim 8
Dependent Claim 9 words
The peptide of claim 4 having the formula X-Tyr-D-Trp-D-Phe-Trp-J.
Claim 9
Dependent Claim 9 words
The peptide of claim 4 having the formula X-Tyr-D-Trp-D-Phe-Phe-J.
Claim 10
Dependent Claim 9 words
The peptide of claim 4 having the formula X-Trp-D-Trp-D-Trp-Trp-J.
Claim 11
Dependent Claim 9 words
The peptide of claim 4 having the formula X-Trp-D-Trp-D-Trp-Phe-J.
Claim 12
Dependent Claim 9 words
The peptide of claim 4 having the formula X-Trp-D-Trp-D-Phe-Trp-J.
Claim 13
Dependent Claim 9 words
The peptide of claim 4 having the formula X-Trp-D-Trp-D-Phe-Phe-J.
Claim 14
Dependent Claim 9 words
The peptide of claim 4 having the formula X-Phe-D-Trp-D-Trp-Trp-J.
Claim 15
Dependent Claim 9 words
The peptide of claim 4 having the formula X-Phe-D-Trp-D-Trp-Phe-J.
Claim 16
Dependent Claim 9 words
The peptide of claim 4 having the formula X-Phe-D-Trp-D-Phe-Trp-J.
Claim 17
Dependent Claim 9 words
The peptide of claim 4 having the formula X-Phe-D-Trp-D-Phe-Phe-J.
Claim 18
Dependent Claim 13 words
The peptide of claim 4 of the formula H 2 N-Tyr-D-Trp-D-Trp-Phe-CONH 2 .
Claim 19
Dependent Claim 9 words
The peptide of claim 4 having the formula X-Tyr-D-Trp-D-Trp-Tyr-J.
Claim 20
Dependent Claim 11 words
The peptide of claim 18 wherein J is --CONH 2 .
Claim 21
Dependent Claim 9 words
The peptide of claim 18 wherein J is --CONHR.
Claim 22
Dependent Claim 13 words
The peptide of claim 18 wherein J is --CONR 1 R 2 .
Claim 23
Dependent Claim 11 words
The peptide of claim 18 wherein J is --CH 2 OR.
Claim 24
Dependent Claim 11 words
The peptide of claim 18 wherein J is --CH 2 OH.
Claim 25
Dependent Claim 9 words
The peptide of claim 18 wherein J is --COOH.
Claim 26
Dependent Claim 9 words
The peptide of claim 18 wherein J is --COOR.
Claim 27
Dependent Claim 10 words
The peptide of claim 18 of the formula H.sub.2 N-Tyr-D-Trp-D-Trp-Tyr-CONH.sub.2.
Claim 28
Dependent Claim 30 words
The peptide of claims 4-16 or 18 wherein each R, R 1 , and R 2 is independently selected from the group consisting of alkyl groups containing 1-2 carbon atoms.
Claim 29
Dependent Claim 13 words
The peptide of claims 4-16 or 18 wherein J is --CONH 2 .
Claim 30
Dependent Claim 19 words
A method of releasing growth hormone from a pituitary comprising contacting said pituitary with the peptide of claim 1.
Claim 31
Dependent Claim 25 words
A method of releasing growth hormone from a pituitary comprising contacting said pituitary with the peptide of claim 1 wherein J is --CONH 2 .
Claim 32
Independent Claim 21 words
A method of releasing growth hormone from a pituitary comprising contacting said pituitary with the peptide of claims 4-25 or 26.
Claim 33
Independent Claim 27 words
A method of releasing growth hormone from a pituitary comprising contacting said pituitary with the peptide of claims 4-15 or 16 wherein J is --CONH 2 .
Claim 34
Dependent Claim 18 words
A compound of the formula Boc-Tyr(BrZ)-D-Trp-D-Trp-Phe-® wherein BrZ is p-bromobenzyloxycarbonyl; Boc is t-butyloxycarbonyl; and ® is benzhydrylamine resin.
Claim 35
Dependent Claim 18 words
A compound of the formula Boc-Tyr(BrZ)-D-Trp-D-Trp-Phe-® wherein BrZ is p-bromobenzyloxycarbonyl; Boc is t-butyloxycarbonyl; and ® is benzhydrylamine resin.
Claim 36
Dependent Claim 18 words
A compound of the formula Boc-Tyr(BrZ)-D-Trp-D-Trp-Tyr(Z)-® wherein BrZ is p-bromobenzyloxycarbonyl; Boc is t-butyloxycarbonyl; and ® is benzhydrylamine resin.
Claim 37
Dependent Claim 18 words
A compound of the formula Boc-Tyr(BrZ)-D-Trp-D-Trp-Tyr(Z)-® wherein BrZ is p-bromobenzyloxycarbonyl; Boc is t-butyloxycarbonyl; and ® is benzhydrylamine resin.

References Cited (Backward Citations)

US3479333A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-09-16 1984-03-17 1984-09-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-09-16 1988-03-17 1988-09-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-09-16 1992-03-17 1992-09-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag